{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:25:03Z","timestamp":1788193503292,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI23\/00047"],"award-info":[{"award-number":["ICI23\/00047"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08961-0","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:33:16Z","timestamp":1756207996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the effectiveness of first-line preventive treatment of migraine in primary care: study protocol for a pragmatic clinical trial (PREMI study)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-9233","authenticated-orcid":false,"given":"Maria","family":"Giner-Soriano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6752-8748","authenticated-orcid":false,"given":"Rosa","family":"Morros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-3971","authenticated-orcid":false,"given":"Ramon","family":"Monf\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8630-152X","authenticated-orcid":false,"given":"Dan","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-8864","authenticated-orcid":false,"given":"Silvia","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-3779","authenticated-orcid":false,"given":"Cristina","family":"Vedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-9221","authenticated-orcid":false,"given":"Sara","family":"Bonet Monn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-7358","authenticated-orcid":false,"given":"Eva Mar\u00eda","family":"Calvo Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Copetti Fanlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-4210","authenticated-orcid":false,"given":"Noem\u00ed","family":"Moroll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Belv\u00eds Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Erika","family":"Delgado-Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-6466","authenticated-orcid":false,"given":"Ana","family":"Garc\u00eda-Sangen\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"8961_CR1","doi-asserted-by":"crossref","unstructured":"Mat\u00edas-Guiu J, Porta-Etessam J, Mateos V, D\u00edaz-Insa S, Lopez-Gil A, Fern\u00e1ndez C. One-year prevalence of migraine in Spain: a nationwide population-based survey. Cephalalgia [Internet]. 2011 ;21;31(4):463\u201370. Available from: https:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/0333102410382794?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed.","DOI":"10.1177\/0333102410382794"},{"key":"8961_CR2","doi-asserted-by":"crossref","unstructured":"Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia [Internet]. 2007;27(3):193\u2013210. Available from: https:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01288.x.","DOI":"10.1111\/j.1468-2982.2007.01288.x"},{"key":"8961_CR3","doi-asserted-by":"crossref","unstructured":"Stovner LJ, Nichols E, Steiner TJ, Abd-Allah F, Abdelalim A, Al-Raddadi RM, et al. Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol [Internet]. 2018;17(11):954\u201376. Available from: http:\/\/www.thelancet.com\/article\/S1474442218303223\/fulltext.","DOI":"10.1016\/S1474-4422(18)30322-3"},{"key":"8961_CR4","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet [Internet]. 2012 Dec 15 [cited 2023 Feb 21];380(9859):2163\u201396. Available from: http:\/\/www.thelancet.com\/article\/S0140673612617292\/fulltext."},{"key":"8961_CR5","unstructured":"Grup d\u2019estudi de cefalees de la Societat Catalana de Neurologia (SCN), Grup d\u2019estudi de la cefalea (GRECAP) de la Societat Catalana de Medicina Familiar i Comunit\u00e0ria (CAMFiC). Consens catal\u00e0 sobre l\u2019atenci\u00f3 al pacient amb migranya. 2015."},{"key":"8961_CR6","unstructured":"Olesen J., Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition Copyright. [cited 2023 Feb 21]; Available from: www.uk.sagepub.com."},{"key":"8961_CR7","doi-asserted-by":"crossref","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, et al. Diagnosis and management of migraine in ten steps. Nature Reviews Neurology 2021 17:8 [Internet]. 2021;17(8):501\u201314. Available from: https:\/\/www.nature.com\/articles\/s41582-021-00509-5","DOI":"10.1038\/s41582-021-00509-5"},{"issue":"S2","key":"8961_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10072-020-04643-8","volume":"41","author":"G Allais","year":"2020","unstructured":"Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020;41(S2):429\u201336.","journal-title":"Neurol Sci"},{"key":"8961_CR9","doi-asserted-by":"crossref","unstructured":"Riesco N, Garc\u00eda-Cabo C, Pascual J. Migraine. Medicina Cl\u00ednica (English Edition) [Internet]. 2016;146(1):35\u20139. Available from: https:\/\/www.elsevier.es\/en-revista-medicina-clinica-english-edition--462-articulo-migraine-S2387020616300894","DOI":"10.1016\/j.medcle.2016.04.048"},{"key":"8961_CR10","unstructured":"Adell V, Belv\u00eds R, G\u00f3mez JB, Cuadrado E, Fabregat N, Garc\u00eda J, et al. Diagn\u00f2stic i tractament de la cefalea Guies m\u00e8diques de la Societat Catalana de Neurologia Diagn\u00f2stic i tractament de la cefalea 2019 COORDINADORS [Internet]. 2019. Available from: https:\/\/www.scneurologia.cat\/wp-content\/uploads\/2019\/07\/Guia-CEFALEES_Societat-Catalana-de-Neurologia_Actualitzaci%C3%B3-2019_DEF.pdf"},{"key":"8961_CR11","unstructured":"Cuadrado-Godia E, Garrido-Alejos G, Marrero P. Tractament de la migranya en adults: de la crisi a la profilaxi. Butllet\u00ed d\u2019informaci\u00f3 terap\u00e9utica [Internet]. 2019;30(5):26\u201332. Available from: http:\/\/scientiasalut.gencat.cat\/handle\/11351\/4348"},{"key":"8961_CR12","unstructured":"EMA - European Medicines Agency. Vydura | European Medicines Agency [Internet]. 2022. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vydura"},{"key":"8961_CR13","unstructured":"EMA - European Medicines Agency. Rayvow | European Medicines Agency [Internet]. 2022. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rayvow"},{"key":"8961_CR14","unstructured":"Scotish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. [Internet]. Edinburgh; 2022. Available from: http:\/\/www.sign.ac.uk"},{"key":"8961_CR15","unstructured":"Santos Lasaosa S, Rosich PP, Nieto RB, Latorre Gonz\u00e1lez G, Gonz\u00e1lez Oria C. Manual de pr\u00e1ctica cl\u00ednica en cefaleas. Recomendaciones diagn\u00f3stico-terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda. 2020."},{"key":"8961_CR16","doi-asserted-by":"crossref","unstructured":"Sch\u00fcrks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ [Internet]. 2009;339(7728):1015. Available from: https:\/\/www.bmj.com\/content\/339\/bmj.b3914","DOI":"10.1136\/bmj.b3914"},{"key":"8961_CR17","doi-asserted-by":"crossref","unstructured":"Kurth T, Kase CS, Sch\u00fcrks M, Tzourio C, Buring JE. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ [Internet]. 2010;341(7771):492. Available from: https:\/\/www.bmj.com\/content\/341\/bmj.c3659","DOI":"10.1136\/bmj.c3659"},{"key":"8961_CR18","unstructured":"Programa d\u2019harmonitzaci\u00f3 farmacoterap\u00e8utica. Erenumab, fremanezumab i galcanezumab per al tractament profil\u00e0ctic de la migranya. [Internet]. Barcelona: Servei Catal\u00e0 de la Salut. Departament de Salut. Generalitat de Catalaunya; 2019. Available from: http:\/\/catsalut.gencat.cat\/ca\/proveidors-professionals\/farmacia-medicaments\/programa-"},{"key":"8961_CR19","doi-asserted-by":"crossref","unstructured":"Ashina M, Lanteri-Minet M, Ettrup A, Christoffersen CL, Josiassen MK, Phul R, et al. Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study. https:\/\/doi.org\/101177\/03331024231170807 [Internet]. 2023;43(5):033310242311708. Available from: https:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/03331024231170807","DOI":"10.1177\/03331024231170807"},{"key":"8961_CR20","unstructured":"EMA - European Medicines Agency. Aquipta | European Medicines Agency [Internet]. 2024. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/aquipta"},{"issue":"1","key":"8961_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-022-01448-2","volume":"23","author":"P Irimia","year":"2022","unstructured":"Irimia P, Garc\u00eda-Azor\u00edn D, N\u00fa\u00f1ez M, D\u00edaz-Cerezo S, de Polavieja PG, Panni T, et al. Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study. J Headache Pain. 2022D 7;23(1):78.","journal-title":"J Headache Pain"},{"key":"8961_CR22","doi-asserted-by":"crossref","unstructured":"Aguilar-Shea AL, Diaz-de-Teran J. Migraine review for general practice. Aten Primaria. 2022;54(2).","DOI":"10.1016\/j.aprim.2021.102208"},{"key":"8961_CR23","doi-asserted-by":"crossref","unstructured":"Kernick D, Kondori N, Pain A, Mount J, Appel C, Ranopa M, et al. Preventive treatment patterns in the adult migraine population: an observational UK study over 7 years. BMC Primary Care [Internet]. 2024;25(1):1\u20139. Available from: https:\/\/bmcprimcare.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12875-023-02242-y","DOI":"10.1186\/s12875-023-02242-y"},{"issue":"3","key":"8961_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143\u201357.","journal-title":"Clin Pharmacokinet"},{"key":"8961_CR25","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Migra\u00f1a y Cefalea. Impacto y situaci\u00f3n de la migra\u00f1a en Espa\u00f1a: Atlas 2018. Universidad de Sevilla, editor. 2018."},{"issue":"9","key":"8961_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2018.1212","volume":"75","author":"VL Stauffer","year":"2018","unstructured":"Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR. Evaluation of galcanezumab for the prevention of episodic migraine. JAMA Neurol. 2018S 1;75(9):1080.","journal-title":"JAMA Neurol"},{"issue":"19","key":"8961_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1001\/jama.2018.4853","volume":"319","author":"DW Dodick","year":"2018","unstructured":"Dodick DW, Silberstein SD, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, et al. Effect of fremanezumab compared with placebo for prevention of episodic migraine. JAMA. 2018M 15;319(19):1999.","journal-title":"JAMA"},{"key":"8961_CR28","doi-asserted-by":"crossref","unstructured":"Goadsby PJ, Reuter U, Hallstr\u00f6m Y, Broessner G, Bonner JH, Zhang F, et al. A controlled trial of erenumab for episodic migraine. New England Journal of Medicine [Internet]. 2017;377(22):2123\u201332. Available from: https:\/\/www.nejm.org\/doi\/https:\/\/doi.org\/10.1056\/NEJMoa1705848","DOI":"10.1056\/NEJMoa1705848"},{"issue":"4","key":"8961_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1590\/S0004-282X2009000600002","volume":"67","author":"RB Domingues","year":"2009","unstructured":"Domingues RB, da Silva ALP, Domingues SA, Aquino CCH, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009;67(4):973\u20137.","journal-title":"Arq Neuropsiquiatr"},{"key":"8961_CR30","doi-asserted-by":"crossref","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Neurology [Internet]. 2012;78(17):1337\u201345. Available from: https:\/\/www.neurology.org\/doi\/https:\/\/doi.org\/10.1212\/WNL.0b013e3182535d20?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed","DOI":"10.1212\/WNL.0b013e3182535d20"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08961-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08961-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:10:45Z","timestamp":1757434245000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08961-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8961"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08961-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial will be conducted in accordance with the protocol, the principles of the Declaration of Helsinki, in accordance with the Tripartite Harmonized Guide for Good Clinical Practice and following the current legal regulations (Royal Decree 1090\/2015, December 4th).The study protocol has been evaluated and approved by the Ethics Committee (CEIm) of the Hospital de la Santa Creu i Sant Pau and authorized by the Spanish Medicines Agency (AEMPS).The informed consent will be requested from all the participants in the trial, respecting their willingness and autonomy in the decision. The participant information sheet will be provided beforehand, and any doubts they may have will be resolved before the trial initiation. Consent will be documented by the signature and date of the patient on the corresponding form, together with the signature and date of the person in charge of the trial explanation and request for consent. The patient or patient\u2019s legal representative must be informed in a timely manner of any information that may have a relevant influence on the patient\u2019s willingness to participate in the study. Two copies of the informed consent will be signed. One copy will be kept by the participant and the other by the investigator, who will keep it in the investigator\u2019s file along with the rest of the study documents. Likewise, it will be documented in the clinical records of the patient that he\/she agrees to participate in the clinical study and who signs the consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent will be obtained directly from the participants, as explained above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"311"}}